This is a global prospective observational study of women with Fabry disease and their infants during pregnancy and/or breastfeeding. The study will evaluate outcomes of pregnancy and/or breastfeeding in women and infants exposed to migalastat.
Protocol Amendment History
6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2020-01-30; most recent amendment 2025-07-02.
Status change: Not Yet Recruiting → Recruiting2020-04-27